Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Arch Soc Esp Oftalmol (Engl Ed) ; 96(1): 48-51, 2021 Jan.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-32600836

RESUMO

The purpose of this report is to describe a case of a unilateral congenital absence of the lacrimal gland in a 7-year-old girl with ocular symptoms, no tear production and a conjunctival tumour at the supero-external angle of the right eye. The visual acuity was 20/20 in both the eyes. The right eye showed mucous secretion, corneal erosions and filaments. Anamnesis, physical examination and clinical tests ruled out systemic diseases associated with congenital alacrima, as well as rheumatic, immunological and infectious diseases. Nuclear magnetic resonance, with various fat suppression techniques, demonstrated the absence of the right lacrimal gland and the presence of a tumour compatible with lipoma. This case, to our knowledge, is the first report of unilateral absence of the lacrimal gland combined with lipoma.

2.
Actas Dermosifiliogr (Engl Ed) ; 112(2): 134-141, 2021 Feb.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-32910923

RESUMO

We present a series of general and specific recommendations based on pathophysiologic considerations for managing the most common adverse effects of apremilast that lead to treatment discontinuation: diarrhea, nausea, and headache. The recommendations are based on a review of the literature and the experience of a multidisciplinary team of 14 experts including dermatologists, rheumatologists, neurologists, gastroenterologists, pharmacists, and nurses. We propose a series of simple algorithms that include clinical actions and suggestions for pharmacologic treatment. The adverse effects of apremilast can be managed from a multidisciplinary approach. The purpose of optimizing management is to bring clinical benefits to patients.


Assuntos
Diarreia/induzido quimicamente , Cefaleia/induzido quimicamente , Náusea/induzido quimicamente , Inibidores da Fosfodiesterase 4/efeitos adversos , Talidomida/análogos & derivados , Terapia Combinada , Diarreia/dietoterapia , Diarreia/tratamento farmacológico , Diarreia/fisiopatologia , Gerenciamento Clínico , Cefaleia/tratamento farmacológico , Cefaleia/fisiopatologia , Cefaleia/prevenção & controle , Humanos , Náusea/dietoterapia , Náusea/tratamento farmacológico , Náusea/fisiopatologia , Equipe de Assistência ao Paciente , Inibidores da Fosfodiesterase 4/uso terapêutico , Guias de Prática Clínica como Assunto , Psoríase/tratamento farmacológico , Talidomida/efeitos adversos , Talidomida/uso terapêutico
3.
Rev Clin Esp ; 187(2): 53-5, 1990 Jun.
Artigo em Espanhol | MEDLINE | ID: mdl-2244057

RESUMO

We present 21 cases of visceral Leishmaniasis diagnosed in our hospital during the past 8 years. The diagnostic method used was the visualization of the parasite in bone marrow aspiratory puncture. All cases presented fever at admission, hepatosplenomegaly, anemia elevated sedimentation rate and polyclonal gammapathy. Two of our patients were diagnosed of AIDS during the course of the disease. Cure was observed in all cases after one cycle treatment with pentavalent antimonials except for the two AIDS cases one of whom died due to cerebral toxoplasmosis. We point out visceral Leishmaniasis as an opportunistic infection in patients with AIDS and its resistance to the usual treatment.


Assuntos
Leishmaniose Visceral/epidemiologia , Síndrome da Imunodeficiência Adquirida/complicações , Adolescente , Adulto , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Leishmaniose Visceral/complicações , Masculino , Pessoa de Meia-Idade , Infecções Oportunistas/epidemiologia , Estudos Retrospectivos , Espanha/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA